TipRanks
Go Ultimate55% OFF

Almirall (LBTSF) Price & Analysis

LBTSF Stock Chart & Stats

$11.80-$0.04(-0.30%)
At close: 4:00 PM EDT
$15.35$15.4$15.4512 Dec9 Feb
Day’s Range
$11.09 - $12.51
52-Week Range
$10.56 - $17.20
Previous Close
$11.84
Volume
N/A
Average Volume (3M)
0
Market Cap
$2.59B
Enterprise Value
$2.41B
Total Cash (Recent Filing)
$355.41M
Total Debt (Recent Filing)
$363.67M
Price to Earnings (P/E)
32.0
Beta
0.61
Next Earnings
Nov 09, 2026
Next Dividend Ex-Date
N/A
Dividend Yield
1.63%

Bulls Say, Bears Say

Bulls Say

Improved Revenue And Profitability

The sharp TTM revenue acceleration alongside positive profitability indicates stronger commercial performance across Almirall’s branded pharmaceutical portfolio. If sustained, improved scale and healthy gross margins can support reinvestment in dermatology products, geographic reach, and lifecycle management.

Conservative And Improving Leverage

Declining leverage and expanding equity provide Almirall with greater financial resilience than its earlier position. A conservative balance sheet can reduce financing pressure, preserve flexibility for product development or partnerships, and help the company absorb fluctuations in pharmaceutical earnings.

Stronger Cash Generation

Strong TTM operating and free cash flow improves Almirall’s ability to fund research, commercialization, licensing activity, and shareholder commitments internally. Robust cash generation also provides a buffer against volatility and reduces reliance on additional borrowing to support growth.

Bears Say

Historical Earnings Volatility

The return to profitability is encouraging, but the multi-year swings in net results make current earnings power less predictable. Continued volatility could complicate planning, reduce confidence in margin durability, and limit the consistency of funds available for investment in the product portfolio.

Inconsistent Cash Flow Quality

Recent cash improvement has not yet established a consistently reliable pattern across the reported history. Earlier negative or breakeven free cash flow suggests that operating performance may not always translate into deployable cash, potentially constraining investment and capital allocation during weaker periods.

Returns Not Fully Normalized

Almirall’s improved profitability has not yet produced strong returns relative to its growing equity base. Persistently modest capital returns would indicate that resources are not being converted into earnings efficiently, limiting the long-term compounding potential of the business despite balance-sheet stability.

Almirall News

LBTSF FAQ

What was Almirall’s price range in the past 12 months?
Almirall lowest stock price was $10.56 and its highest was $17.20 in the past 12 months.
What is Almirall’s market cap?
Almirall’s market cap is $2.59B.
When is Almirall’s upcoming earnings report date?
Almirall’s upcoming earnings report date is Nov 09, 2026 which is in 8 days.
How were Almirall’s earnings last quarter?
Almirall released its earnings results on Jul 24, 2026. The company reported $0.134 earnings per share for the quarter, missing the consensus estimate of $0.146 by -$0.011.
Is Almirall overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Almirall pay dividends?
Almirall pays a Annually dividend of $0.218 which represents an annual dividend yield of 1.63%. See more information on Almirall dividends here
What is Almirall’s EPS estimate?
Almirall’s EPS estimate is 0.09.
How many shares outstanding does Almirall have?
Almirall has 217,777,330 shares outstanding.
What happened to Almirall’s price movement after its last earnings report?
Almirall reported an EPS of $0.134 in its last earnings report, missing expectations of $0.146. Following the earnings report the stock price went up 0.593%.
Which hedge fund is a major shareholder of Almirall?
Currently, no hedge funds are holding shares in LBTSF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology